SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA's upcoming earnings are a major market focus, with some believing the entire market's direction hinges on the results, especially given the recent AI sector pullback. Community discussions range from expectations of a blowout report to fears of a post-earnings sell-off, with some suggesting the AI narrative may be overhyped, while others point to strong demand and potential for growth.

Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. It focuses on its Paxalisib program, which is designed to treat brain cancer. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.

Kazia Therapeutics Limited - ADR

Kazia Therapeutics

KZIA is trending due to promising early results from a Phase 1b trial combining Paxalisib with Keytruda and chemotherapy for triple-negative breast cancer, showing a significant reduction in tumor cells. The community is discussing the potential of this combination therapy and its implications for future cancer treatments. Some investors are closely monitoring the low float, potential for a short squeeze, and upcoming data releases, while others express caution due to the company's financial situation and past stock behavior.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

GRRR is trending as community members discuss the company's recent earnings report, with attention focused on its project pipeline and revenue guidance. Debate centers on the company's cash position, the validity and timing of contracts, and the potential impact of AI-related projects. Analyst ratings and potential buybacks are also being closely watched by investors.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending as investors discuss its potential role in securing critical mineral supplies amid geopolitical tensions and the reopening of government operations; the community is weighing in on the company's value and potential catalysts, such as government approvals and strategic partnerships, while navigating market volatility.

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Strike Coin

Starknet ($STRK) is trending due to increasing BTCFi staking, with mentions of over 1,000 BTC secured on-chain and incentives driving network growth; the community is also buzzing about Starknet's quantum-resistant technology and potential integration with ZCash ($ZEC) for enhanced privacy, leading to speculation about a significant rally.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

Tonix Pharmaceuticals Holding Corp

TNXP is trending due to the increased share repurchase program and upcoming commercial rollout of Tonmya, exciting investors around the company's potential turnaround. The community is actively discussing the implications of the buyback, potential short squeeze opportunities, and revenue projections. Concerns remain around trust in management and past stock performance.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound (COMP) is trending as traders debate its potential amid broader crypto market movements, with some community members expressing concern over its performance compared to other altcoins like AAVE. Discussions include potential treasury issues, governance concerns, and the impact of Bitcoin's price action, while others remain optimistic about a future breakout and its role in Real World Asset (RWA) tokenization. The community is actively weighing COMP's fundamentals against market sentiment.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as investors assess the potential impact of Nvidia's upcoming earnings report amid broader concerns about an AI bubble and recent market volatility. Community discussions revolve around possible market reactions to the report, with some anticipating a significant swing while others remain cautious. Broader market factors, such as potential interest rate cuts and economic data, add to the uncertainty surrounding QQQ's near-term performance.

Rydex Investments - Invesco CurrencyShares British Pound Sterling Trust

Invesco CurrencyShares British Pound Sterling Trust

FXB is trending due to ongoing discussions around the British Pound's value amid factors such as UK economic data, fiscal policy, and speculation about the Bank of England's (BoE) monetary policy decisions. Community members are closely watching how these elements influence the currency's strength against the US dollar, especially in light of evolving global trade dynamics and central bank actions.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

Rapport Therapeutics ($RAPP) is trending as options traders react to recent analyst upgrades and actionable trade alerts, focusing on potential ROI from call options expiring in 2026. The community is weighing positive Phase 2 data against the company's cash runway and potential future catalysts. Discussions also include comparisons to other companies in the sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$AMMPF   Is AmmPower dead, or on life support? 
 
It does not look good to me. 
 
Change is needed, asap. 
 
Not professional investment advice, do your own DD.

StockTwits Web

AmmPower Corp

   Is AmmPower dead, or on life support? 
 
It does not look good to me. 
 
Change is needed, asap. 
 
Not professional investment advice, do your own DD.